Key result
Ultrasound-assisted catheter-directed thrombolysis significantly reduced pulmonary artery pressure and RV/LV ratio, with a pooled all-cause mortality of 3.2% and major bleeding incidence of 5.5%.
Why the study?
Does Ultrasound-Assisted Catheter-Directed Thrombolysis (USAT) improve hemodynamic and imaging parameters while reducing bleeding risk compared to systemic thrombolysis in high-risk and intermediate-high-risk pulmonary embolism?
Meta-Analysis (n=655)
Does Ultrasound-Assisted Catheter-Directed Thrombolysis (USAT) improve hemodynamic and imaging parameters while reducing bleeding risk compared to systemic thrombolysis in high-risk and intermediate-high-risk pulmonary embolism?
USAT effectively improves right ventricular strain and pulmonary hemodynamics in high- and intermediate-high-risk pulmonary embolism with a potentially lower risk of major bleeding compared to systemic thrombolysis.
Answers are grounded in this paper and cite their sources.
Supports USAT preference over systemic thrombolysis to lower major bleeding in PE; reinforces hemodynamic and imaging benefits in meta-analysis.
BACKGROUND: Catheter-directed Ultrasound-Assisted Thrombolysis (USAT) is a novel technology providing a high efficacy with a reduced bleeding risk in patients with pulmonary embolism (PE). METHODS: We performed a meta-analysis based on presented or published PE series in which USAT was utilized. We searched the MEDLINE, EMBASE and the Cochrane Library for trials published up to December 2015. RESULTS: The primary outcomes were mean pulmonary artery pressure (PAMP), right to left ventricle diameter ratio (RV/LV ratio) and computed tomography (CT) obstruction score. The secondary outcomes were all-cause and cardiovascular mortality, major and minor bleeding episodes and recurrent PE. The 11 trials (n=553) and 15 trials (n=655) met eligibility criteria of primary and secondary outcomes, respectively. USAT was found to significantly reduce PAMP, RV/LV ratio and CT obstruction scores. After adjusting for baseline covariates in meta-regression analysis, male sex and number of high-risk patients were found to be associated with PAMP and RV/LV ratio while only male sex was associated with CT obstruction scores. The pooled incidence of all-cause and cardiovascular mortality were 3.2% and 2.2%, and the incidence of major and minor bleeding episodes were 5.5% and 6.9%, respectively. In the pooled analysis of the remaining trials, the incidence of recurrent PE was 1.7%. USAT compared with three randomized thrombolytic trials showed a similar death rate with a lower rate of major bleeding. CONCLUSION: This meta-analysis confirmed that USAT significantly reduced PAMP, RV/LV ratio and CT obstruction scores with similar death rates and a lower risk of major bleeding compared with patients with PE undergoing systemic thrombolytic treatment.
No takes yet. Share an insight, caveat, or question.
Kaymaz et al. (2017) conducted a meta-analysis in High-Risk and Intermediate-High-Risk Pulmonary Embolism (n=655). Ultrasound-Assisted Catheter-Directed Thrombolysis (USAT) vs. Systemic thrombolytic treatment was evaluated on mean pulmonary artery pressure (PAMP), right to left ventricle diameter ratio (RV/LV ratio) and computed tomography (CT) obstruction score. Ultrasound-assisted catheter-directed thrombolysis significantly reduced pulmonary artery pressure and RV/LV ratio, with a pooled all-cause mortality of 3.2% and major bleeding incidence of 5.5%.
Synapse has enriched 10 related papers. Consider them for comparative context: